Statements of Cash Flow (Unaudited) (USD $)	6 Months Ended			99 Months Ended
	Jun. 30, 2012		Jun. 30, 2011	Jun. 30, 2012
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (1,898,950)		$ (1,979,897)	$ (25,758,451)
Adjustment to reconcile net loss to net cash used in operating activities
Amortization of deferred charges				4,392,456
Amortization of prepaid expenses				75,000
Warrants issued for services	142,360		303,758	3,909,807
Stock options issued for services	535,012		628,911	5,508,390
Common stock issued for services and fees	122,058		191,266	1,445,929
Purchase right agreement amortization				132,058
Depreciation and amortization of patents	22,110		16,576	165,537
Realized gain on investments				(3,911)
Realized gain on disposal of assets				(637)
(Increase) decrease in assets
Receivables				(30,461)
Prepaid expenses and other current assets	(81,668)		15,637	(123,424)
Increase (decrease) in liabilities
Accounts payable	(47,715)		40,829	225,033
Accounts payable - related party	6,550		11,951	29,178
Accrued expenses	10,643		44,108	73,222
Net cash used in operating activities	(1,189,600)		(726,861)	(9,960,274)
CASH FLOWS FROM INVESTING ACTIVITIES
Cost of intangibles	(63,366)		(45,230)	(503,153)
Proceeds from sale of available for sale securities				203,911
Proceeds from receipt of note receivable				100,000
Purchase of available for sale securities				(200,000)
Purchase of equipment, furniture and leasehold improvements	(128,236)		(7,281)	(314,481)
Net cash used in investing activities	(191,602)		(52,511)	(713,723)
CASH FLOWS FROM FINANCING ACTIVITIES
Issuance of common stock, private placement				7,495,524
Common stock rescinded, private placement				(200,000)
Issuance of common stock, exercise of options and warrants	444,400			2,021,404
Issuance of common stock, exercise of purchase right agreement				45,138
Issuance of common stock, institutional investor	4,200,000	[1]	200,000	4,400,000
Repayment of notes payable				(14,970)
Proceeds from subscription receivable				19,000
Advances to stockholders				(4,933)
Proceeds from convertible notes				529,000
Advances from officers				1,498
Net cash provided by financing activities	4,644,400		200,000	14,291,661
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS	3,263,198		(579,372)	3,617,664
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	359,824		953,867	5,358
CASH AND CASH EQUIVALENTS - END OF PERIOD	3,623,022		374,495	3,623,022
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION - CASH PAID DURING THE PERIOD FOR:
Interest	109		174	23,341
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Common stock issued in exchange for deferred charges				3,142,400
Warrants issued in exchange for deferred charges				1,581,056
Common stock issued as settlement for accounts payable				74,708
Increase (decrease) in fair value of investment securities
Accrued interest contributed as capital				35,624
Common stock issued in the conversion of notes payable				529,000
Acquisition of automobile through loan payable				24,643
Common stock issued upon exercise of a warrant in exchange for receivable				75,000
Insurance company pay off of note payable				9,673
Receivable for issuance of common stock				210,001
Contribution of officer accrued payroll				52,129
Common stock issued for prepaid expense				$ 75,000

[1] Investment to occur over a period of 30-months.